BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1167433)

  • 1. Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-n-trifluoracetylneuraminic acid (FANA).
    Schulman JL; Palese P
    Virology; 1975 Jan; 63(1):98-104. PubMed ID: 1167433
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).
    Palese P; Schulman JL; Bodo G; Meindl P
    Virology; 1974 Jun; 59(2):490-8. PubMed ID: 4364826
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid on Myxovirus-neuraminidases and the replication of influenza- and Newcastle disease virus].
    Meindl P; Bodo G; Lindner J; Palese P
    Z Naturforsch B; 1971 Aug; 26(8):792-7. PubMed ID: 4399278
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.
    Meindl P; Bodo G; Palese P; Schulman J; Tuppy H
    Virology; 1974 Apr; 58(2):457-63. PubMed ID: 4362431
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.
    Palese P; Compans RW
    J Gen Virol; 1976 Oct; 33(1):159-63. PubMed ID: 978183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of synthetic inhibitors of neuraminidase and hemagglutinin for studying the functional role of active subunits of membranes of myxo- and paramyxoviruses].
    Zakstel'skaia LIa; Molibog EV; Iakhno MA; Evstigneeva NA; Isachenko VA
    Vopr Virusol; 1972; 17(2):223-8. PubMed ID: 4337525
    [No Abstract]   [Full Text] [Related]  

  • 7. [New research on recombination in orthomyxoviruses (author's transl)].
    Podchermiaeva RAa ; Sokolov MI
    Vopr Virusol; 1975; (5):515-20. PubMed ID: 1108449
    [No Abstract]   [Full Text] [Related]  

  • 8. Inability of isoquinoline derivatives to inhibit virus neuraminidase activity.
    Shinkai K; Nishimura T
    J Gen Virol; 1972 Aug; 16(2):227-9. PubMed ID: 5072367
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemolysis by Sendai virus: lack of requirement for neuraminidase.
    Neurath AR; Vernon SK; Hartzell RW; Rubin BA
    J Gen Virol; 1972 Aug; 16(2):245-9. PubMed ID: 4342042
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Gubareva LV; Penn CR; Webster RG
    Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.
    Macdonald SJ; Watson KG; Cameron R; Chalmers DK; Demaine DA; Fenton RJ; Gower D; Hamblin JN; Hamilton S; Hart GJ; Inglis GG; Jin B; Jones HT; McConnell DB; Mason AM; Nguyen V; Owens IJ; Parry N; Reece PA; Shanahan SE; Smith D; Wu WY; Tucker SP
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4542-9. PubMed ID: 15561823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The behavior of genetically purified influenza A2 strains in cell cultures].
    Gerth HJ
    Zentralbl Bakteriol Orig; 1970; 215(1):26-37. PubMed ID: 4992213
    [No Abstract]   [Full Text] [Related]  

  • 13. Selection and in vitro properties of inhibitor-nonsensitive influenza A(H3N2) strains.
    Lecomte J; Boudreault A; Pavilanis V
    Can J Microbiol; 1974 Apr; 20(4):491-8. PubMed ID: 4857251
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect on influenza virus of a modified Francis inhibitor and its acetone-soluble fraction. 3. Experiments on the mouse lung.
    Hollós I
    Acta Microbiol Acad Sci Hung; 1969; 16(2):113-22. PubMed ID: 5377767
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-influenza virus activity of biflavonoids.
    Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
    Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids).
    Serkedjieva J; Manolova N; Bankova V
    J Nat Prod; 1992 Mar; 55(3):294-302. PubMed ID: 1593279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the role of influenza viral neuraminidase in the early stages of the growth cycle by means fo quantitative hemadsorption (author's transl)].
    Shinkai K
    Uirusu; 1974 Aug; 24(2):181-3. PubMed ID: 4478989
    [No Abstract]   [Full Text] [Related]  

  • 18. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
    Yamashita M
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
    Mishin VP; Novikov D; Hayden FG; Gubareva LV
    J Virol; 2005 Oct; 79(19):12416-24. PubMed ID: 16160169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase.
    Itoh M; Hetterich P; Isecke R; Brossmer R; Klenk HD
    Virology; 1995 Oct; 212(2):340-7. PubMed ID: 7571403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.